Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-05-14 @ 5:56 PM
Study NCT ID:
NCT02971956
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2016-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Refractory Advanced Esophageal Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization: